Sweden a leader in advanced therapies 2030
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB - RISE Medicinteknik, Göteborg |
| Funding from Vinnova | SEK 24 800 000 |
| Project duration | November 2019 - November 2024 |
| Status | Ongoing |
| Venture | Vision-driven health |
| Call | Establishment of vision-driven innovation milieus |
Important results from the project
ATMP2030 has become a national hub for ATMP with strengthened international positioning and Swedish coordination. We contributed to ATMP centers at hospitals, CCRM Nordic, the graduate school in Lund, and the hospital pharmacy network. The legal network, ATMPSweden.se, ATMP Sweden conference, and ATMP World Tour were also established. For sustainability, we co-founded the ATMP Sweden association and helped create the Coordination Function for ATMP in Sweden.
Expected long term effects
We hope these achievements make Sweden a global leader in ATMP, strengthening its competitiveness. The goal is a unified nation with effective collaboration between stakeholders, where research, healthcare, and industry drive innovation. Long-term, we also hope that the established structures ensure sustainable development and accessibility of ATMP for patients across Sweden.
Approach and implementation
The project has been driven by a strong core team and around 20 partners with diverse backgrounds, all actively contributing to advancing the vision. The platform and conference have been key tools, as have the passionate individuals pushing development. It’s also important to note that the entire ecosystem has recognized the vision´s importance, and even those not directly involved in the project have contributed and participated in organized initiatives.